Last reviewed · How we verify
Prevention of influenza caused by virus subtypes A and B contained in the vaccine — Treatment Landscape & Competitive Intelligence
1 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Flu Vaccine | Flu Vaccine | La Fundacion Favaloro para la Investigacion y la Docencia Medica | Prophylactic vaccine | Influenza A and B viral hemagglutinin and neuraminidase surface antigens |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- La Fundacion Favaloro para la Investigacion y la Docencia Medica · 1 drug in Prevention of influenza caused by virus subtypes A and B contained in the vaccine
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Prevention of influenza caused by virus subtypes A and B contained in the vaccine:
- Prevention of influenza caused by virus subtypes A and B contained in the vaccine treatment updates — RSS
- Prevention of influenza caused by virus subtypes A and B contained in the vaccine treatment updates — Atom
- Prevention of influenza caused by virus subtypes A and B contained in the vaccine treatment updates — JSON
Cite this brief
Drug Landscape (2026). Prevention of influenza caused by virus subtypes A and B contained in the vaccine — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/prevention-of-influenza-caused-by-virus-subtypes-a-and-b-contained-in-the-vaccine. Accessed 2026-06-10.
Related
- Prevention of influenza caused by virus subtypes A and B contained in the vaccine full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing